On the contrary, very recent evidence indicates that triggering receptor expressed on myeloid cells 2 (TREM2) confers a pro-tumorigenic program to macrophages that interferes with IL-15 release by tumor-infiltrating DCs, thus negatively affecting NK cell activity [146]. The gene discussed is IL15; the disease is neoplasm.